Publications
- The study ODYSSEY CHOICE I with alirocumab: more data on PCSK9 inhibition2017 | First Faculty of Medicine
- Doporučení pro prevenci kardiovaskulárních onemocnění - aktualizace z roku 20212023 | First Faculty of Medicine
- Intervence kardiovaskulárního rizika vyžaduje změnu strategie2023 | First Faculty of Medicine
- Bempedoic acid in the context of current hypolipidemic treatment options and the results of the CLEAR OUTCOMES trial2023 | First Faculty of Medicine
- Parallel intervention of arterial hypertension and dyslipidemia - from risk identification to successful prevention2023 | First Faculty of Medicine
- Comments to recent literature of interest +12023 | First Faculty of Medicine
- Představení výsledků studie CLEAR OUTCOMES2023 | First Faculty of Medicine
- Kyselina bempedová, novinka mezi hypolipidemiky - co můžeme očekávat?2023 | First Faculty of Medicine
- Anti-obesity drug with exceptional benefit for preventive cardiology: current results of the SELECT trial2023 | First Faculty of Medicine
- Aktuality a praktické tipy v léčbě dyslipidemie2023 | First Faculty of Medicine
Loading network view...